Tata Capital Healthcare Fund II (TCHF II), the follow-on healthcare-focused private equity fund under Tata Capital, has concluded seven investments to date. TCHF II has already allocated 60 per cent of the USD 130 million corpus raised last year, it said in a statement.
The fund aims for additional investments in pharmaceutical manufacturing, pharmaceutical distribution and consumer nutrition among others. It expects to add three to four more investee companies by the middle of 2024.
As per the statement, the current TCHF II portfolio is strategically diversified across domestic and export pharmaceuticals, cancer care clinics, dialysis centers, integrated regional diagnostic chains and digital healthcare.
Visalakshi Chandramouli, Managing Partner at Tata Capital Healthcare Fund said, “Our Healthcare Fund is aimed to positively impact people, product and health enterprises. We strongly believe in a transformative approach, underpinned by our 3P framework—People, Process, and Performance. We’re thrilled to report remarkable 9.3 million health beneficiaries both direct and indirect in FY23, 44 new jobs created with USD 1 million invested by the fund and a 35 per cent uptick in women employees across our portfolio companies.”
Categories: Other News